-
BOC Sciences Continues to Expand Its Chemical Offering with Flavor & Fragrance
Jan 22, 2019, 01:25 AM by Michael CroftSHIRLEY, NY, NY, 美国 - Jan 22, 2019 - As the worlds leading chemical supplier of APIs, GMP products, inhibitors, metabolites, impurities and many other general chemicals like natural compounds, BOC Sciences announced to continue to expand its chemical offering with flavor & fragranceFull story -
Creative Peptides Offers Surface Plasmon Resonance Imaging (SPRi) Service for Researchers
Jan 22, 2019, 01:23 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Jan 22, 2019 - As a leading supplier of API peptides, cosmetic peptides, catalog peptides, Creative Peptides has long been famous for its series of pharmaceutical peptide synthesis, analysis and modification servicesFull story -
Deadline For Innovative Practices Awards Entries: What You Need To Know
Jan 21, 2019, 15:20 PM by Michael CroftFull storyBio-IT World | There’s still time to submit an entry for the inaugural Innovative Practices Awards. But the final deadline is coming soon.
-
ProteoGenix develops a tool to select the most appropriate antibody generation technique
Jan 21, 2019, 03:45 AM by Michael CroftSTRASBOURG, FRANCE - Jan 21, 2019 - How to choose between polyclonal antibody production, hybridoma development and antibody phage display? Which is the most appropriate antibody generation technique according to your needs? ProteoGenix, a leading biotech company, has developed an online quizz to help you make your choicexFull story -
CloudLIMS Launches New Instrument Module to Meet ISO/IEC 17025:2017 Requirements
Jan 17, 2019, 01:49 AM by Michael CroftWILMINGTON, US - Jan 17, 2019 - CloudLIMS, a leading laboratory data management informatics provider, announces the release of an Instrument Module for its Laboratory Information Management System (LIMS), CloudLIMSFull story -
EMERSE: How Better Big Data Search Could Change Healthcare
Jan 16, 2019, 09:45 AM by Michael CroftFull storyBio-IT World | The electronic health record (EHR) has become both a blessing and a curse for many people in healthcare. Software tools are now available that can help to leverage the data in these documents, one of which is EMERSE, the electronic medical record search engine.
-
Key Biologics and Cascade Regional Blood Services Partner on Leukapheresis Collections
Jan 15, 2019, 17:49 PM by Michael CroftTACOMA, WA, UNITED STATES - Jan 16, 2019 - Key Biologics LLC and Cascade Regional Blood Services (CRBS) today announced a multi-year agreement to provide researchers in academia, pharma and biotech with vital blood products and materials for their research and product manufacturing effortsFull story -
Niche Biometric CRO launches dedicated pharmacovigilance business
Jan 15, 2019, 10:14 AM by Michael CroftLONDON, UNITED KINGDOM - Jan 15, 2019 - LONDON (UK) - Quanticate, a leading global data-focused clinical research organisation (CRO) has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management servicesFull story -
Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Fourth Consecutive Year
Jan 15, 2019, 09:07 AM by Michael CroftPRINCETON, NJ - Jan 15, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or servicesFull story -
GenScript Launches Instrument For Protein, Antibody Purification
Jan 14, 2019, 15:40 PM by Michael CroftBio-IT World News Brief | GenScript today announced the AmMag SA semi-automatic purification instrument, a novel technology that accelerates and simplifies protein and antibody purification, reducing the process from days to hours.Full story -
How Common Data Could Lead To Uncommon Alzheimer’s Discoveries
Jan 14, 2019, 12:25 PM by Michael CroftFull storyBio-IT World | Now that healthcare and IT are so closely intertwined, the onslaught of data presents possibilities like never before, and those caught up in the effort to save current and future generations from the ravages of Alzheimer’s disease wonder how all this data might be better used to pinpoint patterns of interest and discover pathways for treatments.
-
Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development
Jan 14, 2019, 05:32 AM by Michael CroftBOURNEMOUTH, UK - Jan 14, 2019 - Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreementFull story -
MGI Announces First Customer For MGISEQ-T7, Complete Genomics Accuracy Tech
Jan 11, 2019, 18:20 PM by Michael CroftBio-IT World News Brief | At the J.P. Morgan Healthcare Conference this week, MGI, a subsidiary of global genomics leader BGI Group, announced its first early access customer for the MGISEQ-T7, announced an MGI global sequencer user program, and updated numbers for the product install base. The company released a statement summarizing the presentation.Full story -
The Scope Of Scrutiny
Jan 11, 2019, 12:15 PM by Michael CroftFull storyBio-IT World Contributed Commentary | As biotechnology, pharmaceutical, and medical device companies pursue treatment innovations to improve patient outcomes across diagnoses, many miss a significant step that has been fundamental in financial services and insurance: financial compliance risk management.
-
23andMe Will Add Weight-Loss Advice To Its DNA-Testing Services
Jan 9, 2019, 15:17 PM by Michael CroftBloomberg | Consumer DNA-testing giant 23andMe plans to add new wellness offerings it hopes will help its customers shed a few pounds, but some genetics experts say the jury is still out on the science behind the products.Full story -
Igneous Brings Structure To Unstructured Data With As-A-Service Solution
Jan 9, 2019, 07:40 AM by Michael CroftFull storyBio-IT World | Igneous is offering its cloud-native solution to data-centric organizations in order to both monitor large amounts of data and prevent silos within the clinical research space.
-
Sekisui XenoTech Expands Partnership for Japanese Collection of Research Bioresources Cell Bank (JCRB) Distribution
Jan 8, 2019, 09:22 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Jan 8, 2019 - After 3 years as the official distributor of JCRB cell lines in North America, Sekisui XenoTech has expanded its agreement with the National Institute of Biomedical Innovation to include distribution to EuropeFull story -
Creative Diagnostics Introduces Pathology Antibodies for Researchers
Jan 7, 2019, 22:56 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Jan 8, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now is proud to announce that it launches a number of high quality pathology antibodies including Her2, PD-1, Ki-67, Tim3, CTLA4, Lp-PLA2, Muc2, Cytokeratin 18, BRAF V600E, IDH1 R132H, MLH1, MSH2, MSH6, and PMS2Full story -
Eli Lilly Makes An $8B Cancer Genetics Bet With Loxo Acquisition
Jan 7, 2019, 10:09 AM by Michael CroftXconomy | Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion---a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.Full story -
10x Genomics Announces $35m Funding
Jan 7, 2019, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | On day one of the JP Morgan Healthcare Conference, 10x Genomics announces $35 million in funding as an extension of its Series D financing.